SCHEMBL21494448

SCHEMBL21494448

CC(=O)Oc1c([N+](=O)[O-])cnc2ccc(Br)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.46
TSHR P16473 1/20 0.46
PTGES O14684 1/20 0.39
MAPT P10636 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
EGFR P00533 3/20 0.39
ALDH1A1 P00352 3/20 0.38
MAPK1 P28482 2/20 0.38
TNF P01375 1/20 0.38
POLB P06746 1/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
NOD2 Q9HC29 1/20 0.38
NOD1 Q9Y239 1/20 0.38
CYP1A2 P05177 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21494374 0.86 HTT (0.45) HTTTSHRPTGESMAPTMEN1
SCHEMBL21494401 0.84 HTT (0.39) HTTTSHRPTGESMAPTMEN1
SCHEMBL21494361 0.83 HTT (0.38) HTTTSHRPTGESMAPTMEN1
SCHEMBL21494375 0.83 HTT (0.40) HTTTSHRPTGESMAPTMEN1
SCHEMBL358629 0.78 MAPT (0.45) HTTTSHRPTGESMAPTMEN1
SCHEMBL1557518 0.78 LMNA (0.41) HTTTSHRPTGESMAPTMEN1
SCHEMBL28468025 0.76 EGFR (0.42) HTTTSHRPTGESMAPTMEN1
SCHEMBL26129153 0.76 HTT (0.46) HTTTSHRMAPTMEN1KMT2A
SCHEMBL358123 0.75 EGFR (0.42) HTTTSHRPTGESMAPTMEN1
SCHEMBL20319134 0.75 CTSB (0.42) HTTTSHRPTGESMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3784671-A1 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRad Therapeutics, Inc. (US) 2021-03-03 EP disclosed
WO-2019201283-A1 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRAD THERAPEUTICS, INC. (US) 2019-10-24 WO disclosed